Ruixin Regenerative
Nanjing · Founded 2019
About Ruixin Regenerative
Ruirui Regeneration is a small molecule pharmaceutical R&D manufacturer dedicated to the development of new technologies for somatic cell reprogramming and regenerative medicine. The development of small molecule drugs reverses tissue and organ fibrosis and achieves in situ regeneration of functional cells for chronic heart failure and liver. The treatment of a variety of major diseases that are difficult to cure, such as aging, provides a completely new solution.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Angel (May 2019)
Industries & Categories
Health Care, Manufacturing, Pharmaceutical
Canonical: https://fsome.com/organization/ruixin-regenerative-173849 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.